AliveCor
The news comes roughly eight months after Apple launched its own hardware and software ECG feature for the Apple Watch Series 4.
Priya Abani will take up the digital health company's top role on Monday, while interim CEO Ira Bahr will shift to the COO position.
The KardiaMobile 6L builds upon its predecessor with a third electrode placed on its back side, allowing cardiologists better insight into device owners' arrhythmias.
KardiaMobile and KardiaStation warn users when detecting bradycardia and tachycardia. Meanwhile, the company has also laid the groundwork for streamlined AI updates across all of its current and upcoming products.
The company has received multiple clearances as it gears up for the release of its next-generation smartphone-connected ECG platform.
Partner AliveCor also got a mysterious new FDA clearance.
AliveCor’s KardiaMobile five times more effective at detecting heart arrhythmia than standard tests…
Researchers have now called for the device to be incorporated into standard care in A&E departments.
Interim CEO Ira Bahr said that his company is undeterred by Apple's entrance into the mobile ECG market.
Also: EverlyWell's first chief marketing officer; Livongo's mental health hires.
As AI cements its role in healthcare, more and more intelligent software offerings are pursuing 510(k) and De Novo approvals.